SEIBF yields 0.82% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, SEIBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEIBF + PFE for your $10,000?
Seibu Holdings Inc. engages in the urban and regional transportation, hotel and leisure, real estate, construction, and baseball team management businesses in Japan and internationally. It operates through Urban Transportation and Regional, Hotel and Leisure, Real Estate, and Other Business segments. The company offers railway, bus, and taxi transportation services; operates hotels, hot springs and spas, golf courses, ski resorts, tennis courts, bowling alleys, skating rinks, fitness clubs, and other leisure facilities; develops and sells housing, condominiums, and resort properties; leases office and residential facilities; and develops and operates stores in train stations, shopping malls, and other commercial facilities. It also maintains a professional baseball team under Saitama Seibu Lions name; hosts concerts and other non-baseball events through Belluna Dome; and operates and manages amusement parks, aquariums, movie theaters, and pools. In addition, the company offers fire insurance, automobile insurance, travel insurance, and life insurance products. Further, it provides travel agency; housekeeping; child-rearing support; home and urban development services; and pet care products, as well as builds cemeteries. Seibu Holdings Inc. was incorporated in 2006 and is headquartered in Tokyo, Japan.
Full SEIBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.